Suppr超能文献

石胆酸葡萄糖醛酸苷是一种胆汁淤积剂。

Lithocholate glucuronide is a cholestatic agent.

作者信息

Oelberg D G, Chari M V, Little J M, Adcock E W, Lester R

出版信息

J Clin Invest. 1984 Jun;73(6):1507-14. doi: 10.1172/JCI111356.

Abstract

Lithocholic acid and its taurine, glycine, and sulfate derivatives are potent cholestatic agents. Lithocholate glucuronide is present in the plasma and urine of patients with cholestatic syndromes, but little is known of its metabolism, excretion, and cholestatic potential. [3 beta-3H]lithocholate 3-O-beta-D-glucuronide was synthesized, and chemical and radiochemical purity were established. The aqueous solubility of lithocholate glucuronide was determined and found to be greater than that of lithocholic acid or several of its derivatives. In the range of concentrations examined, calcium ions precipitated lithocholate glucuronide stoichiometrically. The material was administered to rats prepared with an external biliary fistula. When 17-25 micrograms quantities were administered, 89.1 +/- 4.5% (mean +/- SEM) of the radiolabel was secreted in bile within the first 20 h after administration, the major fraction being secreted in less than 20 min. Four-fifths of the radiolabeled material in bile was the administered unaltered parent compound, while a minor fraction consisted of a more polar derivative(s). We showed that increasing biliary concentrations of more polar derivatives were observed with milligram doses of [3H]lithocholate glucuronide, and with time after the administration of these loading doses. Milligram doses of [3H]lithocholate glucuronide resulted in partial or complete cholestasis. When induced cholestasis was partial, secretion in bile remained the primary excretory route (82.5-105.6% recovery in bile), while, when complete cholestasis was induced, wide tissue distribution of radiolabel was observed. Cholestasis developed rapidly during infusion of [3H]lithocholate glucuronide. Bile flow was diminished within 10-20 min of the start of an infusion of 0.05 mumol, 100 g-1 body weight, minute-1, administered concomitantly with an equimolar infusion of taurocholate. The results establish that lithocholate glucuronide exerts cholestatic effects comparable to those exerted by unconjugated lithocholic acid.

摘要

石胆酸及其牛磺酸、甘氨酸和硫酸盐衍生物是强效的胆汁淤积剂。石胆酸葡萄糖醛酸苷存在于胆汁淤积综合征患者的血浆和尿液中,但其代谢、排泄及胆汁淤积潜力鲜为人知。合成了[3β - 3H]石胆酸3 - O - β - D - 葡萄糖醛酸苷,并确定了其化学和放射化学纯度。测定了石胆酸葡萄糖醛酸苷的水溶性,发现其水溶性大于石胆酸或其几种衍生物。在所检测的浓度范围内,钙离子能按化学计量沉淀石胆酸葡萄糖醛酸苷。将该物质给予制备了体外胆瘘的大鼠。当给予17 - 25微克剂量时,给药后最初20小时内89.1±4.5%(平均值±标准误)的放射性标记物分泌到胆汁中,大部分在20分钟内分泌。胆汁中五分之四的放射性标记物质是未改变的给药母体化合物,而一小部分由极性更强的衍生物组成。我们发现,给予毫克剂量的[³H]石胆酸葡萄糖醛酸苷后,随着时间推移,胆汁中极性更强的衍生物浓度会升高。毫克剂量的[³H]石胆酸葡萄糖醛酸苷会导致部分或完全胆汁淤积。当诱导的胆汁淤积为部分性时,胆汁分泌仍是主要排泄途径(胆汁回收率为82.5 - 105.6%),而当诱导完全胆汁淤积时,观察到放射性标记物在组织中的广泛分布。在输注[³H]石胆酸葡萄糖醛酸苷期间胆汁淤积迅速发展。在以0.05微摩尔/100克体重/分钟的速度输注[³H]石胆酸葡萄糖醛酸苷并同时等摩尔输注牛磺胆酸盐开始后的10 - 20分钟内,胆汁流量减少。结果表明,石胆酸葡萄糖醛酸苷发挥的胆汁淤积作用与未结合的石胆酸相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/605b/437060/077c5a3b01a6/jcinvest00156-0017-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验